CAS 915087-33-1hair Loss Treatment Enzalutamide Anti Prostate Cancer Enzalutamide Powder Anti Prostate Cancer Enzalutamide

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: D-Sung-Enzalutamide
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Product Name: Enzalutamide
• Name: Enzalutamide Powder
• Appearance: White Powder
• Color: White
• Grade: Pharmaceutical Grade
• Assay: HPLC 99%
• Application: Antineoplastic
• Specific: COA
• Test Method: HPLC
• Shelf Life: 2 Years
• CAS No: 915087-33-1
• Mf: C21h16f4n4o2s
• MW: 464.44
• Refractive Index: 1.629
• Density: 1.49
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-sung
• Origin: Shaanxi Xi′an
• Production Capacity: 500kg/Month

Product Description

CAS 915087-33-1Hair Loss Treatment Enzalutamide Anti Prostate Cancer Enzalutamide Powder Anti Prostate Cancer Enzalutamide

Product Description

Product Details

Product name	Enzalutamide
Appearance	White powder
CAS NO.	915087-33-1
MF	C21H16F4N4O2S
MW	464.44

Enzalutamide is a second-generation androgen receptor (AR) signaling inhibitor. It is able to inhibit binding of androgens to the AR, AR nuclear translocation, and the association of the AR with DNA.

Application&Function

1. The basic mechanism of action of enzalutamide: Enzalutamide inhibits the activity of androgen receptors, interferes with androgen signaling, and thereby suppresses the growth and spread of prostate cancer cells. It not only prevents androgens from binding to receptors but also inhibits the nuclear translocation and DNA binding of the receptors, thereby enhancing the anti-tumor effect.
2. Application in castration-resistant prostate cancer: In the treatment of castration-resistant prostate cancer, enzalutamide has become a standard treatment option.
3. Application in patients with biochemical recurrence: For high-risk patients with biochemical recurrence of prostate cancer, enzalutamide combined with androgen deprivation therapy (ADT) has shown superior efficacy.
4. Safety and tolerability of enzalutamide: The safety of enzalutamide has been thoroughly evaluated in multiple clinical trials and is generally well tolerated.

Specification

 

 

 

 

 

Packaging & Shipping